The Relapse Phenomenon in Mild COVID Treated With Nirmatrelvir/Ritonavir in an Immunocompetent Patient

Dtsch Arztebl Int. 2022 Sep 16;119(37):619-620. doi: 10.3238/arztebl.m2022.0267.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Chronic Disease
  • Humans
  • Recurrence

Substances

  • Antiviral Agents